Annual CFI
$72.66 M
+$518.72 M+116.29%
December 31, 2023
Summary
- As of February 6, 2025, ITOS annual cash flow from investing activities is $72.66 million, with the most recent change of +$518.72 million (+116.29%) on December 31, 2023.
- During the last 3 years, ITOS annual CFI has risen by +$73.03 million (+19372.68%).
- ITOS annual CFI is now at all-time high.
Performance
ITOS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$91.49 M
-$107.81 M-660.53%
September 30, 2024
Summary
- As of February 6, 2025, ITOS quarterly cash flow from investing activities is -$91.49 million, with the most recent change of -$107.81 million (-660.53%) on September 30, 2024.
- Over the past year, ITOS quarterly CFI has dropped by -$153.05 million (-248.63%).
- ITOS quarterly CFI is now -248.63% below its all-time high of $61.56 million, reached on December 31, 2023.
Performance
ITOS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$83.21 M
-$114.18 M-368.68%
September 30, 2024
Summary
- As of February 6, 2025, ITOS TTM cash flow from investing activities is -$83.21 million, with the most recent change of -$114.18 million (-368.68%) on September 30, 2024.
- Over the past year, ITOS TTM CFI has dropped by -$155.87 million (-214.53%).
- ITOS TTM CFI is now -214.53% below its all-time high of $72.66 million, reached on December 31, 2023.
Performance
ITOS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ITOS Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +116.3% | -248.6% | -214.5% |
| 3 y3 years | +10000.0% | -10000.0% | -6748.7% |
| 5 y5 years | +10000.0% | -10000.0% | -8886.2% |
ITOS Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +116.3% | -248.6% | +79.5% | -214.5% | +82.6% |
| 5 y | 5-year | at high | +116.3% | -248.6% | +79.5% | -214.5% | +82.6% |
| alltime | all time | at high | +116.3% | -248.6% | +79.5% | -214.5% | +82.6% |
ITeos Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$91.49 M(-660.5%) | -$83.21 M(-368.7%) |
| Jun 2024 | - | $16.32 M(-123.5%) | $30.97 M(-10.9%) |
| Mar 2024 | - | -$69.60 M(-213.1%) | $34.75 M(-52.2%) |
| Dec 2023 | $72.66 M(-116.3%) | $61.56 M(+171.3%) | $72.66 M(-116.7%) |
| Sep 2023 | - | $22.69 M(+12.9%) | -$434.02 M(-5.0%) |
| Jun 2023 | - | $20.10 M(-163.4%) | -$456.82 M(-4.3%) |
| Mar 2023 | - | -$31.69 M(-92.9%) | -$477.43 M(+7.0%) |
| Dec 2022 | -$446.06 M(>+9900.0%) | -$445.12 M(>+9900.0%) | -$446.06 M(>+9900.0%) |
| Sep 2022 | - | -$105.00 K(-79.6%) | -$1.10 M(-27.9%) |
| Jun 2022 | - | -$514.00 K(+59.1%) | -$1.53 M(+3.8%) |
| Mar 2022 | - | -$323.00 K(+100.6%) | -$1.47 M(+18.7%) |
| Dec 2021 | -$1.24 M | -$161.00 K(-69.7%) | -$1.24 M(+2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$532.00 K(+16.2%) | -$1.22 M(+54.2%) |
| Jun 2021 | - | -$458.00 K(+403.3%) | -$788.00 K(+82.8%) |
| Mar 2021 | - | -$91.00 K(-32.1%) | -$431.00 K(+14.3%) |
| Dec 2020 | -$377.00 K(-59.3%) | -$134.00 K(+27.6%) | -$377.00 K(+31.4%) |
| Sep 2020 | - | -$105.00 K(+4.0%) | -$287.00 K(+6.3%) |
| Jun 2020 | - | -$101.00 K(+173.0%) | -$270.00 K(-22.0%) |
| Mar 2020 | - | -$37.00 K(-15.9%) | -$346.00 K(-62.6%) |
| Dec 2019 | -$926.00 K(+209.7%) | -$44.00 K(-50.0%) | -$926.00 K(+5.0%) |
| Sep 2019 | - | -$88.00 K(-50.3%) | -$882.00 K(+11.1%) |
| Jun 2019 | - | -$177.00 K(-71.3%) | -$794.00 K(+28.7%) |
| Mar 2019 | - | -$617.00 K | -$617.00 K |
| Dec 2018 | -$299.00 K | - | - |
FAQ
- What is iTeos Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for iTeos Therapeutics?
- What is iTeos Therapeutics annual CFI year-on-year change?
- What is iTeos Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for iTeos Therapeutics?
- What is iTeos Therapeutics quarterly CFI year-on-year change?
- What is iTeos Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for iTeos Therapeutics?
- What is iTeos Therapeutics TTM CFI year-on-year change?
What is iTeos Therapeutics annual cash flow from investing activities?
The current annual CFI of ITOS is $72.66 M
What is the all time high annual CFI for iTeos Therapeutics?
iTeos Therapeutics all-time high annual cash flow from investing activities is $72.66 M
What is iTeos Therapeutics annual CFI year-on-year change?
Over the past year, ITOS annual cash flow from investing activities has changed by +$518.72 M (+116.29%)
What is iTeos Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of ITOS is -$91.49 M
What is the all time high quarterly CFI for iTeos Therapeutics?
iTeos Therapeutics all-time high quarterly cash flow from investing activities is $61.56 M
What is iTeos Therapeutics quarterly CFI year-on-year change?
Over the past year, ITOS quarterly cash flow from investing activities has changed by -$153.05 M (-248.63%)
What is iTeos Therapeutics TTM cash flow from investing activities?
The current TTM CFI of ITOS is -$83.21 M
What is the all time high TTM CFI for iTeos Therapeutics?
iTeos Therapeutics all-time high TTM cash flow from investing activities is $72.66 M
What is iTeos Therapeutics TTM CFI year-on-year change?
Over the past year, ITOS TTM cash flow from investing activities has changed by -$155.87 M (-214.53%)